CLINICAL_TRIALS
trial_result
· 2021-08-12
Clinical Trial Update: Pharmacokinetic and PHarmacodynamic Analysis and Evaluation of Teriparatide (PTH 1-34) Between Sexes [Phase 3]
Summary
Phase 3 trial evaluating PK/PD of teriparatide (PTH 1-34) with a focus on sex differences in stress fracture patients; completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Norfolk and Norwich University Hospitals NHS Foundation Trust | Conditions: Stress Fracture | Phase 3 | Status: COMPLETED